Clinical Trials
41 trialsUsing a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Memorial Sloan Kettering Cancer Center
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
ACE-HIGH
Ottawa Hospital Research Institute
TALENTOP
Fudan University
Comparison of Vascular Catheter-Related Thrombosis and Risk Factors After Oncologic and Non-Oncologic Major Surgery
Mersin University
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients
Sixth Affiliated Hospital, Sun Yat-sen University
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
ONCO PE
Kyoto University, Graduate School of Medicine
PREPOSTEROUS
Helsinki University Central Hospital
MVTEP2/SOME2
University Hospital, Brest
Thrombosis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
ONCO DVT
Kyoto University, Graduate School of Medicine
CANVAS
Alliance Foundation Trials, LLC.
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
Ésquilo
Hospital do Servidor Publico Estadual
SOME-RIETE
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
University of Utah
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
China-Japan Friendship Hospital
3DUrologia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery
Istanbul Medeniyet University
DVT
University of Texas Southwestern Medical Center
PREVENTER
Johns Hopkins University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
DVT
Beni-Suef University
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
LiuZhou People's Hospital
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
The University of Hong Kong
Functional Training for the Prevention of Deep Venous Thrombosis
Peking Union Medical College Hospital
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
M.D. Anderson Cancer Center
ALICAT
Cardiff University
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
DISOLVE
University of Vermont
CAP
University Hospital, Akershus
Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
University of Alabama at Birmingham
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
High-dose Periop Statins for Prevention of DVT
Yale University
SOME
Ottawa Hospital Research Institute
Longheva
University Medical Center Groningen
PERI-OP
Ottawa Hospital Research Institute
Cancer-DACUS
Azienda Ospedaliera Universitaria Policlinico
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Ontario Clinical Oncology Group (OCOG)